DexGard Review | Is DexGard Legit or a Scam? High-Risk DeFi Derivatives Platform with No Regulation or Audit

Company and Platform Basic Information

I. Platform Background and Positioning

On October 18, 2025, DexGard released a white paper preview, positioning itself as a **"perpetual contract DEX for institutional and high-frequency traders"**.
The project claims to be developed by a Singapore-based team and aims to become a "hybrid alternative to Uniswap and dYdX".
However, it was not registered with the Monetary Authority of Singapore (MAS) and did not disclose the name of the team or its legal entity.

Its slogan is:

“Low Fees. Deep Liquidity. True On-Chain Trading.”

From a technical perspective, DexGard plans to use zkRollup technology to implement an architecture that combines on-chain and off-chain matching.
Users can sign orders through smart contracts and complete settlement on the blockchain.

However, neither the official website nor the GitHub repository currently provides the source code or audit report.
The platform's security and compliance could not be verified.

II. Technical Architecture and Transaction Mechanism

DexGard claims three core advantages:

1. On-chain matching engine (Hybrid Matching)

• User orders are first matched by off-chain matching nodes.

• The transaction results are then confirmed on the blockchain to ensure transparency.

2. low cost structure

• Transaction fees are 0.01%–0.03%, significantly lower than dYdX.

• LPs (liquidity providers) receive a 50% commission.

3. Capital pool and collateral mechanism

• Users need to pledge USDT or USDC as margin;

• If losses exceed the limit, the system will automatically trigger liquidation;

• Liquidity is supported by LP pools, rather than traditional market makers.

However, in actual testing (October 29, 2025),
The platform only offers a "simulated environment" and does not support real on-chain fund transfers.
The transaction record cannot be found in any block explorer.

III. Regulatory and Compliance Issues

DexGard's official white paper mentions "Singapore entity registered in progress".
However, no company number or registration certificate was provided.
In the Monetary Authority of Singapore (MAS) public database ( https://eservices.mas.gov.sg/fid ),
No results were found for "DexGard" or any related company name.

In addition, the platform claims to be "completely decentralized".
However, its domain name is hosted by Cloudflare in the United States, and its master node is located in AWS Singapore.
This means that technically it belongs to a DEX hybrid with a centralized entry point .

From a regulatory perspective, DexGard does not have the following:

• Digital Payments License (DPT Licence) issued by MAS

• Capital Markets Services Licence

• Registration information for financial advisors or clearing businesses

Therefore, from a legal perspective, DexGard is not a regulated financial institution .
It belongs to the category of "unregistered decentralized derivatives platforms," similar to dYdX (registered in the Cayman Islands).
However, no risk disclosures or terms were made public.

DexGard Review | Is DexGard a Scam? A Real Analysis of the Risks and Regulatory Roles of Decentralized Derivatives Platforms (Part 2)

IV. User Feedback and Community Activity

DexGard will launch its Twitter and Discord channels in early October 2025, and currently has fewer than 5,000 followers.
The community's main activities focus on airdrop events, points-based tasks, and marketing announcements, with no substantial transactions or development progress yet.

In the Discord group, most users reported the following:

• The testnet is accessible but has extremely low mobility;

• The contract address has not yet passed any mainstream security audits (such as CertiK or PeckShield);

• Official team members remain anonymous, identified only as "DexGard Core Team";

• The technical documents are mostly AI-generated translations, and some links are broken.

Furthermore, on Reddit and Crypto Twitter, some users pointed out that the project may have used open-source code templates from other small DEXs.
Furthermore, some of the promotional materials are almost identical to those of the now-defunct "DexaSwap".
All indications suggest that DexGard has not yet entered the actual operation stage and is more focused on concept packaging and token pre-launch hype.

V. Risk Matrix and Compliance Assessment

Overall risk score: 2.3 / 10 (High risk / Unregulated)

VI. Potential Problems and Safety Hazards

1. Unregulated + Anonymous Team
   DexGard is not registered in Singapore or any other jurisdiction.
   If security vulnerabilities or financial losses occur, investors will have nowhere to hold anyone accountable.

2. Contract Risks
   Smart contracts are unaudited and may contain backdoors, slippage manipulation, or liquidation anomalies.

3. Token economic design flaws
   The official claim is that the total supply of DEXG tokens is 100 million, but no lock-up plan or distribution rules have been announced.
   If the team controls the majority of the supply, it will create a risk of price manipulation.

4. Centralized entry point disguised as decentralized
   Despite claiming to be a DEX, the domain name, nodes, and API are all centralized on a single server.
   If the domain name or backend is blocked, user assets may become inaccessible.

VII. FAQ (Frequently Asked Questions)

Q1: Is DexGard regulated in Singapore?
❌ No. Not found in the MAS Financial Registry database.

Q2: Is the platform open source?
⚠️ Some smart contract examples are publicly available, but the core matching engine's source code is not open source.

Q3: Is there a security audit?
❌ No official or third-party audit report.

Q4: Do you support real funds?
⚠️ As of October 2025, the platform is still in a test environment and does not support mainnet funds.

Q5: Is it recommended for ordinary users to participate?
🚫 Not recommended. The risks are currently extremely high, with a lack of regulation and transparency.

VIII. Conclusion

DexGard does not yet possess the necessary conditions for a mature decentralized derivatives platform.
Technically, it remains in the early testing phase; the team is anonymous, there is no regulatory authorization, and no audit verification.
It's more like a "speculative concept package" than a truly compliant project.

In the current regulatory environment, any unregistered and unaudited high-leverage DEX should be considered a potentially risky asset .
If DexGard actually releases its audit report and registers the entity in the future, it may be possible to reassess.

Current conclusion: DexGard is a high-risk project, and we do not recommend investing or depositing funds into it.

👉 Go to the BrokerHiveX exposure section ,
View the latest lists of high-risk trading platforms, unregulated DEXs, and investor warnings.